Experimental peptide receptor radionuclide therapy in radioiodine negative somatostatin receptor positive thyroid cancer

被引：0
|
作者：
Nilica, B. [1 ]
Kroiss, A. [1 ]
Putzer, D. [1 ]
Uprimny, C. [1 ]
Warwitz, B. [1 ]
Kendler, D. [1 ]
Waitz, D. [1 ]
Virgolini, I. [1 ]
机构：
[1] Univ Klin Nukl Med, Innsbruck, Austria
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S125 / S125
页数：1
相关论文
共 50 条
  • [1] Peptide Receptor Radionuclide Therapy in Thyroid Cancer
    Gubbi, Sriram
    Koch, Christian A.
    Klubo-Gwiezdzinska, Joanna
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [2] Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours
    Van Essen, Martijn
    Krenning, Eric P.
    De Jong, Marion
    Valkema, Roelf
    Kwekkeboom, Dik J.
    [J]. ACTA ONCOLOGICA, 2007, 46 (06) : 723 - 734
  • [3] Peptide receptor radionuclide therapy (PRRT) for progressive, somatostatin receptor positive pheochromocytoma/paraganglioma
    Prasad, V.
    Zachert, C.
    Schuchardt, C.
    Wortmann, R.
    Baum, R. P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S351 - S351
  • [4] First experience in proteasome inhibitor therapy of dedifferentiated, radioiodine negative, somatostatin- receptor negative thyroid cancer
    Putzer, Daniel
    Gabriel, Michael
    Eisterer, Wolfgang
    Kendler, Dorota
    Prommegger, Rupert
    Madleitner, Ruth
    Dobrozemsky, Georg
    Gastl, Guenther
    Virgolini, Irene
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [5] Can peptide receptor radionuclide therapy (PRRT) be useful in radioiodine-refractory differentiated thyroid cancer?
    Campenni, Alfredo
    Pignata, Salvatore A.
    Baldari, Sergio
    [J]. ENDOCRINE, 2015, 50 (02) : 516 - 518
  • [6] Peptide receptor-mediated radionuclide therapy for treatment of the somatostatin receptor-positive tumors
    Mojtahedi, Alireza
    Pandit-Taskar, Neeta
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2013, 54
  • [7] Can peptide receptor radionuclide therapy (PRRT) be useful in radioiodine-refractory differentiated thyroid cancer?
    Alfredo Campennì
    Salvatore A. Pignata
    Sergio Baldari
    [J]. Endocrine, 2015, 50 : 516 - 518
  • [8] Peptide receptor radionuclide therapy for non-radioiodine-avid differentiated thyroid carcinoma
    Teunissen, JJM
    Kwekkeboom, DJ
    Kooij, PPM
    Bakker, WH
    Krenning, EP
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2005, 46 : 107S - 114S
  • [9] Is There a Role for Peptide Receptor Radionuclide Therapy in Medullary Thyroid Cancer?
    Vaisman, Fernanda
    Rosado de Castro, Paulo Henrique
    Proenca Lobo Lopes, Flavia Paiva
    Kendler, Daniel Barretto
    Pessoa, Cencita H. N.
    Bulzico, Daniel Alves
    Leal, Douglas de Carvalho
    Vilhena, Bruno
    Vaisman, Mario
    Carneiro, Michel
    Corbo, Rossana
    [J]. CLINICAL NUCLEAR MEDICINE, 2015, 40 (02) : 123 - 127
  • [10] Peptide Receptor Radionuclide Therapy (PRRT) of Medullary and Nonmedullary Thyroid Cancer Using Radiolabeled Somatostatin Analogues
    Salavati, Ali
    Puranik, Arneya
    Kulkarni, Harshad R.
    Budiawan, Hendra
    Baum, Richard P.
    [J]. SEMINARS IN NUCLEAR MEDICINE, 2016, 46 (03) : 215 - 224
12345